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Abstract
Background: Worldwide, there is a need to expand the number of drugs available to treat parasitic infections in
aquaculture. One of the new materials being tested is metal nanoparticles, which have unique chemical and
physical characteristics owing to their extremely small size and high surface area to volume ratio. We examined the
effectiveness of gold nanoparticles against the microsporidian parasite Heterosporis saurida, which causes severe
economic losses in lizard fish, Saurida undosquamis aquaculture.
Results: We synthesized gold nanoparticles by chemical reduction of tetrachloroauric acid as a metal precursor. We
assessed the antimicrosporidial efficacy of the nanoparticles against H. saurida using an in vitro screening approach,
which we had developed previously using the eel kidney cell line EK-1. The number of H. saurida spores produced
in EK-1 cells was reduced in a proportional manner to the dosage of gold nanoparticles administered. A cell metabolic
activity test (MTT) indicated that the gold nanoparticles did not appear to be toxic to the host cells.
Conclusions: Gold nanoparticles can act as an effective antimicrosporidial agent and hold promise to reduce disease
in lizardfish aquaculture. Metal nanoparticles should be considered as an alternate choice for development of new
antimicrosporidial drugs to combat disease problems in aquaculture.
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Background
Saurida undosquamis (Richardson, 1848) also known as
Brushtooth lizardfish is fish species of the Synodontidae
family. S. undosquamis is a Lessepsian migrant species
distributed across the Indo-West Pacific including the
Red Sea, Persian Gulf, Eastern Africa, Japan and
Australia [1]. S. undosquamis invaded the Levant Basin
of the Mediterranean Sea, from the Indo-West Pacific
through the Suez Canal [2] and is considered one of the
most successful colonizers of the Eastern Mediterranean,
extending as far as the Aegean Sea [3]. The Mediterranean
lizardfish population now has significant commercial value
[4] in the eastern Mediterranean, where it is considered
one of the most common species caught in the trawl
fishery [5].
Diseases are a major obstruction to expansion of fresh
water and marine aquaculture. Fish are susceptible to
many pathogens, often with severe consequences [6].
Microsporidia are single-celled, obligate intracellular
parasites that infect invertebrates and vertebrates. More
than one thousand microsporidian species have been
recognized as causing diseases in animals and humans
[7]. Microsporidia are common in marine, fresh water
and estuarine systems, and affect economically import-
ant fish species worldwide, including salmonids [8], flat-
fish [9], greater sand eels (Hyperoplus lanceolatus) [10]
and ornamental fish, such as zebrafish (Danio rerio) [11]
and killifish (Family Cyprinodontidae) [12]. Infections
caused by microsporidia reduce the growth rate of fish
and decrease production in aquaculture [13, 14]. Re-
cently, H. saurida was isolated from lizardfish (Fig. 1)
where it infects skeletal muscle, body cavity and mesen-
teric tissues and forms white, cyst-like structures, which
contain numerous spores making the fish unsuitable for
public consumption [15].
Only a small number of anti-parasitic drugs are per-
mitted in aquaculture, as the cost of drug development
is high and the market small. The few available treat-
ments for microsporidiosis differ in their effectiveness,
and as with many drug treatments, there is concern for
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the pathogens developing resistance to one or multiple
antibiotics [16]. A promising, alternative approach that
has received recent attention is the use of metallic nano-
particles, which have distinct advantages over conven-
tional antimicrobial agents [17, 18]. Nanometer-sized
materials have unique, extraordinary and fascinating phys-
ical, chemical, and biological properties, particularly a
large contact area with microorganisms because of their
small size and higher surface-to-volume ratio; a property
that expands their biological and chemical activity. Cur-
rently, nanoparticles with one dimension of 100 nm or
less have received immense interest as an alternative
means of combatting infectious agents in medicine. Metal
based nanoparticles display broad spectrum antimicrobial
activity against bacteria, fungi and viruses [19–24].
The most widespread antimicrobial compounds are
silver and benzalkonium chloride [25, 26]. Unfortu-
nately, in a comparable manner where scientists develop
new efficient antimicrobial materials, there is no doubt
that resistance to silver also is increasing [16]. Therefore,
a number of metals, mainly copper, have been used as
an antimicrobial agent. Gold has been little explored as
an antimicrobial agent, although it has been used as a
catalyst [27, 28].
Gold nanoparticles in particular, have a broad range of
applications in nano-scale devices and technologies due
to their chemical inertness and resistance to surface oxi-
dation [29]. Gold nanoparticles have been investigated as
an antimicrobial agent to inhibit the growth of common,
waterborne, pathogens Escherichia coli and Salmonella
typhi, which are developing resistance to common bacte-
ricides [30]. In aquaculture, several studies have been
carried out to investigate gold nanoparticles as anti-
microbial drugs [31–33].
In vivo efficiency trials for anti-parasitic drugs are ex-
pensive, time intensive, and need ethical permission,
hence new and efficient systems to screen compounds
while reducing animal experiments are required. One
alternative, cost-effective approach is to screen com-
pounds using relevant animal cell lines. In the case of H.
saurida, in vitro propagation has been demonstrated for
both mammal (rabbit kidney; [34]) and fish (eel kidney
EK-1; [35]) cell lines and an in vitro screening approach
using the EK-1 cells to test antimicrosporidial agents
against the parasite was also developed [36], however,
our aim in the present study was to investigate the in
vitro antimicrosporidial activity of gold nanoparticles as
a potential agent against H. saurida infections.
Methods
Ethics statement
No ethical approval was necessary as this study did not
involve laboratory animals; it comprised in vitro testing
of cultured cell lines and microsporidian spores.
Propagation of H. saurida spores
Heterosporis saurida spores were grown in the eel fish
kidney cell line (EK-1) using procedures previously de-
scribed [35]. Briefly, H. saurida spores were collected
from naturally infected lizard fish, Saurida undosquamis
[15]. EK-1 cells were sub-cultured, seeded in 24-well
plates in triplicate and supplemented with L-15 medium
(Leibovitz) containing L-glutamine (Sigma-Aldrich), 10 %
fetal bovine serum (FBS) (Sigma-Aldrich), 100 units/ml
penicillin and 100 μg/ml streptomycin (Sigma-Aldrich,
Vienna, Austria). Twenty four hours after seeding, 100 μl
(~107 spores/ml) of spore suspension was added to each
well. Twenty-four hour post-inoculation (p.i.), the medium
was removed and the cells rinsed gently 3 times with fresh
medium; the medium was replace twice per week.
Preparation and characterization of gold nanoparticles
We followed the protocol of Storhoff et al. [37] to
synthesize gold nanoparticles (~13 nm diameter) by re-
duction of 10 mM tetrachloroauric acid (HAuCl4) using
sodium citrate (Sigma-Aldrich, Vienna, Austria). Briefly,
an aqueous solution of HAuCl4.3H2O was boiled under
reflux while being stirred. The color of the solution
changed from yellow to deep red after rapid addition of
10 ml 1 % trisodium citrate. The color change signified
formation of monodispersed spherical gold nanoparti-
cles. The solution refluxed for an additional 15 min, then
allowed to cool to room temperature. The solution was
subsequently filtered through a 0.45 μm acetate filter
and stored at 4 °C. A stock concentration of 1 mg/ml
gold nanoparticles was used in the assays.
Morphology, size, and shape of synthesized gold nano-
particles were characterized using transmission electron
microscopy (TEM). Samples were prepared by drop cast-
ing a 2.5 mL aliquot of the Au NPs suspension onto a
300 mesh carbon-coated copper grid. The gold suspen-
sion was dried at room temperature for 5 min and over-
load solution was removed from the grid using blotting
paper. Particles were imaged using a Zeiss EM109. The
Fig. 1 The microsporidian parasite Heterosporis saurida infects the
lizard fish Saurida undosquamis and forms white, cyst-like structures
in the muscles
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size distribution of particles was estimated by images
analysis of 100 nanoparticles located at different regions
of the grid (n = 3). Images were taken of several samples
(n = 3) to produce statistically meaningful results.
Measurement of anti-microsporidial activity of gold
nanoparticles
Twenty-four well culture plates were loaded with EK-1
cells at a concentration of 1.5 × 105 cells/ml in L-15
medium containing 10 % FBS, and penicillin-streptomycin
solution (Sigma-Aldrich, Vienna, Austria). The plates were
incubated overnight at 26 °C to allow a cell monolayer to
form. To reach a final ratio of 3:1 spores/cell, H. saurida
spores were added in 1 ml volumes of medium at a con-
centration of 106 –107 spores/ml. Non-adherent spores
were washed off after 24 h, and fresh medium with 0,
0.01, 0.1 and 1.0 μg/ml gold nanoparticles was added to
wells, and incubated for 7 days. Media was replaced every
three days. Cell monolayers were examined daily with an
inverted microscope, and 10 cells in 10 fields were viewed
per well using a 40X objective, for each treatment group
(6 wells each treatment and control). Each concentration
was tested in triplicate and the inhibition of H. saurida
spore propagation was calculated as percent inhibition =
100 – [(mean number of H. saurida spores counted in
treated cultures/mean number of H. saurida spores
counted in non-treated cultures) × 100]. The differences
between treated and non-treated H. saurida spores were
analyzed using t-tests with Bonferroni α-correction. A
p-value < 0.05 was regarded as significant for all statis-
tical tests. Statistical analyses were carried out using
SPSS version-20 software.
Visual observations and measurement of drug toxicity
EK-1 cells were plated in 96-well plates at approximately
1.5 × 104 cells per well. After 24 h, the medium was re-
placed with fresh medium containing different concen-
trations of gold nanoparticles as described above.
Cellular viability of EK-1 cultures after introduction to
the gold nanoparticles was examined as above. Any toxic
effects were noted, such as cells becoming sub-confluent
or altered in morphology compared with non-treated
control cells. Plates were incubated at 26 °C for 1 week.
The medium was then removed and the viability of cul-
tures was assayed by incubating with MTT (3-[4,5-di-
methylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide,
Sigma-Aldrich), following the method described by
Mosmann [38]: 20 μl MTT (5 mg/ml in balanced salt
solution) was added to each well and incubated for 2 h.
After that, medium of each well was discarded, and
200 μl of MTT solubilization solution (Sigma-Aldrich)
was added and the plates agitated with an orbital shaker.
Triplicate absorbance values of each well were measured
in a microplate reader at 570 nm against a reference
wavelength of 690 nm. The percentage of cell viability
was calculated as the optical density values of treated
cells divided by the mean optical density of non-treated
cells, multiplied by100.
Re-infection of EK-1 cells with H. saurida recovered after
gold nanoparticles treatments
To determine if H. saurida spores were still infectious
after treatment with gold nanoparticles, spores were re-
covered from each culture well on day 7, by addition of
100 μl of 10 % (w/v) sodium dodecyl sulfate. Released
spores were centrifuged at 400 g for 15 min and washed
3 times with Tris-buffered saline containing Tween 20
(0.3 %). Spore pellets were re-suspended in medium and
used to infect new cultures as previously described. A
hemocytometer was used to count spores gold nanopar-
ticles from treated and non-treated wells: 1 ml of spores
suspension was adjusted to 1x104 spores/ml and then
added to each well. Fresh medium without gold nano-
particles was added on day 3. Each culture well was
observed under an inverted microscope and spores were
counted 3 times (10 field/well).
Results
Gold nanoparticles
TEM revealed that the mean diameter of gold nanoparti-
cles was 11.06–14.22 nm, and particles were spherical
(Fig. 2). TEM also showed that the gold nanoparticles
suspension was in a monodispersional state without
obvious aggregations.
Measurement of anti-microsporidial activity of gold
nanoparticles
Gold nanoparticles significantly reduce (p < 0.001) the
number of H. saurida spores produced by infected cells,
in a concentration-dependent manner (Fig. 3). The num-
bers of spores observed in 10 infected EK-1 cells in 10
fields of 6 wells were recorded and are listed in Table 1.
Fig. 2 TEM micrograph of gold nanoparticles showing that most of
the gold nanoparticles are round/spherical with a size range
of 11.06–14.22 nm
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Cultures with 0.01 μg/ml gold nanoparticles had fewer
H. saurida spores than control cell cultures. Propagation
of H. saurida spores was inhibited 68 and 75 % by
0.1 μg/ml and 1 μg/ml gold nanoparticles, respectively.
Cellular and nuclear shapes appeared normal at all gold
nanoparticle concentrations.
Drug toxicity measurements
Cell viability was monitored using MTT assay after incu-
bation for 7 days with different concentrations of gold
nanoparticles. Effects of gold nanoparticles tested con-
centrations were analyzed using MTT assay and results
are shown in Table 1.
Re-infection of EK-1 cells with recovered H. saurida spores
Since it was not appropriate to verify if these spores
were mature or infectious by microscopic observation,
EK-1 cells were re-infected with recovered H. saurida
spores after treatment.
Significantly fewer infectious microsporidia spores
were recovered after treatments with gold nanoparticles
in a concentration-dependent manner when compared
with non-treated cultures (Table 1).
Discussion
Host- pathogen interactions are usually multivalent, and
the interplay between microbes and host cells often
involves several copies of multiple receptors and ligands
that bind in a coordinated way to allow the microbial
agent to take the cell under control. Interfering with
these recognition events, by effectively crowding out
pathogen entry into the cells, is one of the most promis-
ing strategies being investigated for drug development
[21]. Due to the emergence of diseases and increased
mortalities in aquaculture, and the development of drug
resistance by aquatic microbes, there is an ongoing effort
to investigate alternative methods of prevention and
control of diseases [24]. A growing attention in com-
pounds with antimicrobial characteristics is rising due to
their wide application potential in various fields includ-
ing medicine [39, 40].
The present study was conducted to find out if gold
nanoparticles demonstrate antimicrosporidial activity
against the aquatic microsporidian Heterosporis saurida
in vitro.
We synthesized the gold nanoparticles (13 nm diameter)
by reduction of 10 mM tetrachloroauric acid (HAuCl4)
with sodium citrate.
TEM shows that most of the gold nanoparticles are
round and spherical in shape and in a monodispersional
state without obvious aggregations that is due to the
negatively charged coating layer of citrate ions, which
leads to electrostatic repulsion and prevents aggregation
of gold nanoparticles.
We screened different concentrations of the nanopar-
ticles for activity against H. saurida in EK-1 cells. Cell
cultures treated with even the lowest concentration
(0.01 μg/ml) of gold nanoparticles produced fewer H.
saurida spores than control cell cultures (Table 1). At a
concentration of 0.1 μg/ml, production of spores was
inhibited more than 65 %, and at 1.0 μg/ml, inhibition
was more than 75 %. The inhibitory rates obtained in
this study are close to those observed when other poten-
tial antimicrosporidial drugs were used [36].
We conducted MTT assays to determine if health of
host cells was adversely affected, after incubation for
7 days with different concentrations of gold nanoparti-
cles. Negligible cytotoxicity was observed up to concen-
trations of 0.01 μg/ml, and < 35 % toxicity was found at
the highest concentrations tested (1 μg/ml). These re-
sults are consistent with the low cytotoxicity reported
Fig. 3 Effect of gold nanoparticles against Heterosporis saurida in
EK-1 cells. Cells were infected with the spores of H. saurida and
incubated with different concentrations of gold nanoparticles. Data
are mean (± SD) numbers of spores in 6 wells of infected EK-1 cells
Table 1 Effects of different concentrations of gold nanoparticles on proliferation of Heterosporis saurida and infectivity of the recovered
spores in EK-1 cell cultures
Concentration of gold
nanoparticles




Cell viability (%) Mean numbers of H. saurida
spore (infected cells/10 fields)
0.01 μg/ml 303 ± 12.3 28.4 89.6 ± 1.7 9
0.1 μg/ml 133 ± 7.1 68.6 70.9 ± 2.2 5
1 μg/ml 104 ± 6.7 75.5 69.8 ± 1.3 3
Non-treated control cells 423 ± 15.4 - - 67
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previously for gold nanoparticle conjugates [41]. It has
been suggested that gold nanoparticles increase perme-
ability of the cell wall that leads to leakage of cell con-
tents and cell death. Furthermore, gold nanoparticles
have been shown to bind to the DNA of microorganisms
and inhibit the DNA transcription process [41, 42]. Re-
cently, conjugates of gold nanoparticles were investi-
gated and reported not to be generally cytotoxic and
non-specific host cell membrane disruptors but affect
the transcription of a number of micro-organisms genes
including those involved in cell division [43]. Similarly,
in this study gold nanoparticles have been shown not to
be generally toxic because the viability of the EK-1 cells
was not greatly affected as confirmed with MTT test.
Gene expression studies would be required to clarify the
molecular mechanistic effects of gold nanoparticles on
H. saurida, though it has been suggested that the nano-
particles may alter expression of genes related to parasite
cell division [43]. The mechanism of action may also
involve an increase in permeability of the cell walls, lead-
ing to leakage of cell contents and death [41, 42].
Conclusions
This study shows that gold nanoparticles demonstrate a
considerable antimicrosporidial activity against the fish
microsporidian H. saurida in vitro. However, further
investigations concerning mode of action and functionali-
zation of gold nanoparticles to increase their antimicros-
poridial activity, reduce possible in vivo accumulation
related toxicity and enhance and promote their use in
aquaculture are still needed.
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